Nuclear transport modulators and uses thereof
AssigneeKaryopharm Therapeutics Inc.
InventorErkan Baloglu
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula (I) or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Claims44
A compound of structural formula (Ia), (Ib), or (Ic):
- or a pharmaceutically acceptable salt thereof, wherein:
- each R1, if present, is independently selected from —CF3, halo, —OH, C1-C3 alkyl, C3-C6 cycloalkyl, 3-18-membered heterocyclyl, halo-C1-C3 alkyl, —NH2, —NO2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)(C1-C3 alkyl), —C(O)OH, —C(O)O—(C1-C6 alkyl), —C(O)—(C1-C3 alkyl), —O—(C1-C3 alkyl), —O—(C1-C3 haloalkyl), and —S—(C1-C3 alkyl);
- R2 and Rb are each independently selected from:
- —C(O)—N(R5)(R6), halogen, C(O)—O—R3, —C(O)—N(R7)—N(R5)(R6), —C(O)—N(R7)—N(R7)—C(O)—R4 and —C(O)—N(R7)—N(R7)—S(O)1-2—R4, a 6-18-membered aryl or a 5-18-membered heteroaryl;
- R3 is selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C18 carbocyclyl, C6-C18 aryl, 3-18-member heterocyclyl and 5-18-member heteroaryl;
- R4 is selected from —N(H)(C3-C6 cycloalkyl), —N(C1-C4 alkyl)(C3-C6 cycloalkyl), —C1-C6 alkyl, —(C0-C4 alkylene)-C3-C18 carbocyclyl, —(C0-C4 alkylene)-3-18-member heterocyclyl, —(C0-C4 alkylene)-C6-C18 aryl, and —(C0-C4 alkylene)-5-18-member heteroaryl;
- R5 and R6 are each independently selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C18 carbocyclyl, C6-C18 aryl, 3-18-member heterocyclyl and 5-18-member heteroaryl;
- or
- R5 and R6 are taken together with the nitrogen atom to which they are commonly attached to form a 3-18-member heterocyclyl or 5-18-member heteroaryl;
- and
- each R7 is independently hydrogen or C1-C4 alkyl;
- n is 0, 1, 2, 3, 4 or 5;
- wherein, unless otherwise designated, each alkyl, alkenyl, alkynyl, alkylene, carbocyclyl, aryl, cycloalkyl, heterocyclyl and heteroaryl is optionally and independently substituted.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound represented by any one of the following structural formulas:
- or a pharmaceutically acceptable salt thereof.
(canceled)
A compound represented by any one of the following structural formulas:
- or a pharmaceutically acceptable salt thereof.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.